Third vaccine boosters and anti‐S‐IgG levels: A comparison of homologous and heterologous responses...
Third vaccine boosters and anti‐S‐IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma
About this item
Full title
Author / Creator
Publisher
BP, Asia: Wiley Publishing Asia Pty Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BP, Asia: Wiley Publishing Asia Pty Ltd
Subjects
More information
Scope and Contents
Contents
The immune response of patients with chronic liver disease tends to be lower after receiving their second coronavirus disease 2019 (COVID‐19) vaccine dose, but the effect of a third vaccine dose on their immune response is currently unknown. We recruited 722 patients without previous severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infe...
Alternative Titles
Full title
Third vaccine boosters and anti‐S‐IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9264613b93fd4a70ac8cddf8bfe3e0c6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9264613b93fd4a70ac8cddf8bfe3e0c6
Other Identifiers
ISSN
1607-551X
E-ISSN
2410-8650
DOI
10.1002/kjm2.12812
